Retrospective evaluation of risk determinants in prodromal period with a group of schizophrenia patients

被引:3
|
作者
Cakmak, Soner [1 ]
Karaytug, Mahmut Onur [1 ]
Bal, Ufuk [2 ]
Tamam, Lut [1 ]
Tasdemir, Ali [1 ]
机构
[1] Cukurova Univ, Fac Med, Dept Psychiat, Adana, Turkey
[2] Askim Tufekci Hosp, Psychiat Clin, Adana, Turkey
来源
CUKUROVA MEDICAL JOURNAL | 2016年 / 41卷 / 03期
关键词
Schizophrenia; risk factors; psikoz;
D O I
10.17826/cukmedj.234960
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: This study aims to investigate the significance of risk determiners in the occurence of schizophrenia. and the link between the severity of determiners and the duration to full-blown schizophrenia. Material and Methods: Patients older than 18 years old, diagnosed with schizophrenia are included in our study. SOPS (Scale of Prodromal Symptoms) is applied to determine the risk of schizophrenia prodromal period, scale scores are calculated and patients are classified in accordance to risk syndrome criteria defined in SIPS (Structured Interview for Prodromal Symptoms). Results: Prodromal symptoms are detected in 68 of 100 patients. Of those 68 patients, 47 met the criteria for Attenuated Positive Prodromal Syndrome (APPS), 20 met the criteria for Brief Intermittent Psychotic Syndrome (BIPS), 24 met the criteria for Genetic Risk and Deterioration Syndrome (GRDS), 67 met the criteria for Psychotic Syndrome (PS), 44 met the criteria for Attenuated Psychosis Syndrome (APS) in DSM-5. Grandiosity, perceptual abnormalities/hallucinations, poverty of thought, deterioration in a role functioning, peculiar behaviour and appearance, decreased tolerance to normal stress are manifested to be meaningful in APPS, Conclusion: It's clear that prodromal symptoms are increasing markedly the odds of psychosis and schizophrenia occurance in respect to normal population. Nevertheless, further customization and elaboration of risk determining criteria, searching and displaying neurobiological risk factors among criteria, will help to reliably identify risk groups and detect disorder in prodromal period.
引用
收藏
页码:437 / 446
页数:10
相关论文
共 50 条
  • [1] Retrospective study of prodromal symptoms in schizophrenia
    Rofes, L
    Bueno, A
    Valero, J
    Labad, A
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2003, 31 (01): : 35 - 39
  • [2] PRODROMAL SYMPTOMS OF SCHIZOPHRENIA: A RETROSPECTIVE TUNISIAN STUDY
    Triki, R.
    Hajeri, S.
    Johnson, I.
    Cherif, W.
    Tabbane, K.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [3] Prodromal depression in pancreatic cancer: Retrospective evaluation on 10 patients
    Sebti, Johan
    Desseigne, Francoise
    Saltel, Pierre
    PALLIATIVE & SUPPORTIVE CARE, 2015, 13 (03) : 801 - 807
  • [4] Evaluation of the prodromal period of bipolar disorder
    Noto, M. N.
    Noto, C.
    Mansur, R.
    Chaves, A.
    Correll, C. U.
    Brietzke, E.
    BIPOLAR DISORDERS, 2013, 15 : 143 - 143
  • [5] Executive functioning in patients with schizophrenia prodromal syndrome
    Decombas, M.
    Geneste, J.
    Courty, E.
    SCHIZOPHRENIA RESEARCH, 2006, 86 : S92 - S93
  • [6] Regional neurochemical abnormalities in patients with prodromal schizophrenia
    Juckel, G
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 112S - 113S
  • [7] Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk"
    Corcoran, C
    Malaspina, D
    Hercher, L
    SCHIZOPHRENIA RESEARCH, 2005, 73 (2-3) : 173 - 184
  • [8] The association between schizophrenia and smoking:: Unexplained by either the illness or the prodromal period
    Diaz, Francisco J.
    Velasquez, Diana M.
    Susce, Margaret T.
    de Leon, Jose
    SCHIZOPHRENIA RESEARCH, 2008, 104 (1-3) : 214 - 219
  • [9] Divergence of inhibitory measures in prodromal schizophrenia: Defining subgroups at-risk for schizophrenia
    Cadenhead, KS
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 140S - 140S
  • [10] Clinical-psychopathological peculiarities of the prodromal period of psychosis in patients with paranoid schizophrenia and acute polymorph psychotic disorder
    Maruta, N. O.
    Bilous, V. S.
    EUROPEAN PSYCHIATRY, 2018, 48 : S323 - S323